dihexa phenolic pka Values — Hans Reich Collection — a) pKa values of different

Safety and Tolerability Cerebrolysin: Well-Established Safety Profile Cerebrolysin benefits from decades of post-marketing surveillance and clinical trial safety data: Clinical Trial Safety: Across multiple RCTs, Cerebrolysin has demonstrated a tolerability profile comparable to placebo in most studies, with adverse events generally mild and transient Common Side Effects: Injection site reactions, dizziness, headache, and nausea are the most frequently reported adverse events at standard clinical doses Serious Adverse Events: Rare at therapeutic doses

Conventional treatments range from rest and ice to custom orthotics, physical therapy, night splints, extracorporeal shock wave therapy, and corticosteroid injections

Isobaric labeling was performed using a TMT-18plex kit

insufficient human RCT evidence

Total vial volume appears separately